Hudson Bay Capital Management »

Supernus Pharmaceuticals shares owned by Hudson Bay Capital Management

Quarter-by-quarter ownership of Supernus Pharmaceuticals (SUPN) shares owned by Hudson Bay Capital Management from 13F filings

Historical chart of Hudson Bay Capital Management investment in Supernus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Supernus Pharmaceuticals held by Hudson Bay Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Supernus Pharmaceuticals by Hudson Bay Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $4.7M 91k 51.69

More positions owned by Hudson Bay Capital Management

NVIDIA Corporation Call Option (NVDA)
Tesla Motors Call Option (TSLA)
Amazon Call Option (AMZN)
Apple Call Option (AAPL)
Palantir Technologies Cl A Call Option (PLTR)
Netflix Call Option (NFLX)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Advanced Micro Devices Call Option (AMD)
State Str Spdr S&p 500 Etf T Tr Unit Call Option (SPY)
Berkshire Hathaway Inc Del Cl B New Put Option (BRK.B)
Microsoft Corporation Call Option (MSFT)
Echostar Corp Note 3.875%11/3 (Principal)
Taiwan Semiconductor Manufac Sponsored Ads Put Option (TSM)
Flagstar Bank National Assoc Com New (FLG)
UnitedHealth Put Option (UNH)

View all positions for Hudson Bay Capital Management

Top funds holding Supernus Pharmaceuticals

BlackRock
Vanguard Group
Millennium Management
Vanguard Portfolio Management
Vanguard Capital Management
Dimensional Fund Advisors
State Street Corporation
Nomura Asset Management International
Armistice Capital
Renaissance Technologies
Geode Capital Management
Citadel Advisors
Loomis, Sayles and
Stephens Investment Management Group
Point72 Asset Management

View all funds holding Supernus Pharmaceuticals